MyAverix Finance
US · Healthcare
Hikma Pharmaceuticals PLC ADR (HKMPY)
Drug Manufacturers - Specialty & Generic
Hikma Pharmaceuticals PLC ADR (HKMPY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported market cap is $3.62B, P/E ratio is 18.00, net margin is 12.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HKMPY
Hikma Pharmaceuticals PLC ADR (HKMPY) — FAQ
What is Hikma Pharmaceuticals PLC ADR's market cap?
Hikma Pharmaceuticals PLC ADR (HKMPY) has a reported market cap of $3.62B (data as of 2026-03-24).
What is HKMPY's P/E ratio?
The price-to-earnings (P/E) ratio for Hikma Pharmaceuticals PLC ADR (HKMPY) is 18.00 (data as of 2026-03-24).
Does Hikma Pharmaceuticals PLC ADR pay a dividend?
Dividend yield is not available in the current snapshot for Hikma Pharmaceuticals PLC ADR (HKMPY). Check the MyAverix Finance app for the latest dividend data.
What sector is Hikma Pharmaceuticals PLC ADR in?
Hikma Pharmaceuticals PLC ADR (HKMPY) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is HKMPY listed on?
HKMPY is listed on US.
What is Hikma Pharmaceuticals PLC ADR's net margin?
Hikma Pharmaceuticals PLC ADR (HKMPY) reports a net margin of 12.0% (data as of 2026-03-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.